Relicensing exposure in an acquisition target.

A target's value lives partly in its software, and its software runs on open source the seller may never have mapped. When a component in that stack has relicensed, the obligation does not pause for the transaction. Relicensing exposure in an acquisition target passes to the buyer at close, whether or not anyone priced it. The good news is that this risk is findable. A dependency tree review during diligence turns a hidden liability into a known number the deal team can act on, and the difference between finding it before and after close is the difference between a negotiating point and an absorbed cost.

What relicensing exposure in an acquisition target looks like

Relicensing exposure takes a few recognizable forms. A target may run software that moved to the Business Source License or the Server Side Public License, which can mean a commercial license fee or a forced migration the seller deferred. It may carry components under a strong copyleft license such as the GNU AGPL, whose distribution and network use obligations follow the code into the combined entity. It may depend on a project that has already forked, leaving the target on an aging restricted version while the open path moved elsewhere. Each of these is a cost or a constraint, and each is invisible until the dependency tree is mapped. The relicensing wave of recent years means more targets carry this than buyers expect.

Why it belongs in the valuation conversation

A relicensing obligation is a future cash cost, which makes it a valuation item, not a footnote. If the target must pay a commercial license to keep running a component competitively, or migrate off it within a year, that spend reduces what the business is worth to the buyer. Surfaced during diligence with a remediation cost attached, the exposure can be reflected in the price, covered by an indemnity, or made a condition of close. Surfaced after close, it is simply the buyer's problem. The discipline is to treat the dependency tree as a source of valuation adjustments rather than a compliance checkbox. We cover the broader pattern in relicensing risk in your vendor stack.

What a target dependency review covers

A diligence grade review maps the full dependency tree, direct and transitive, and records the current license of every component rather than the license it carried when the target adopted it. It flags any component that has relicensed, any that sits under a copyleft obligation, and any that depends on a project that has forked. To each material finding it attaches a remediation cost, so the output is quantified exposure, not a list of concerns. The deliverable is a red flag memo the deal team can use at the table, with the largest items sized and the path to cure each one noted. An anonymised example of this work sits in the acquirer that found hidden SSPL risk in a target.

Run it on the deal timeline

The review only protects the buyer if it lands while there is leverage. That means running it alongside financial and legal diligence, not after the deal signs, so any finding can move the price or the terms. The work is fast when the target has a current bill of materials and slower when it does not, which is itself a signal about the maturity of the target's governance. Where the target has no inventory, the review builds one, which doubles as an asset the combined entity keeps. The copyleft obligations that often drive these findings are explained in the manufacturer that quantified AGPL exposure before a deal.

Turn findings into deal terms

A quantified finding is only useful if it changes the agreement. Material relicensing exposure can be handled in several ways: a price reduction equal to the remediation cost, a specific indemnity for the obligation, an escrow against the migration, or a condition that the seller cure it before close. Which lever fits depends on the size of the exposure and the structure of the deal, and the choice of language is a matter for your own counsel. What matters from the risk side is that the exposure is named, sized, and on the table rather than discovered later. The full approach to acquirer side diligence sits in our pillar on M and A and compliance, and the acquirer focused engagement is described in open source due diligence for acquirers.